129 related articles for article (PubMed ID: 270404)
1. Schedule dependent effectiveness of CCNU and 5-fluorouracil in experimental chemotherapy.
Mulder JH; Smink T; Van Putten LM
Eur J Cancer (1965); 1977 Oct; 13(10):1123-31. PubMed ID: 270404
[No Abstract] [Full Text] [Related]
2. Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapy.
Mulder JH; Edelstein MB; Lelieveld P; van Putten IM
Eur J Cancer (1965); 1978 May; 14(5):537-42. PubMed ID: 648568
[No Abstract] [Full Text] [Related]
3. Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC).
Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
Cancer; 1979 Sep; 44(3):858-63. PubMed ID: 476597
[No Abstract] [Full Text] [Related]
4. Etretinate, lomustine, and bleomycin versus lomustine and bleomycin in advanced squamous cell lung carcinoma.
Weber W; Obrecht JP
Cancer Treat Rep; 1983 Sep; 67(9):847-9. PubMed ID: 6192913
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.
Bernath AM; Cohen MH; Ihde DC; Fossieck BE; Matthews MJ; Minna JD
Cancer Treat Rep; 1976 Sep; 60(9):1393-4. PubMed ID: 189924
[No Abstract] [Full Text] [Related]
6. Effects of nandrolone decanoate on the toxicity and anti-tumour action of CCNU and FU in murine tumours.
Bibby MC; Double JA; Mughal MA
Br J Cancer; 1981 Oct; 44(4):572-7. PubMed ID: 7295514
[TBL] [Abstract][Full Text] [Related]
7. Intraneoplastic injection of CCNU for experimental brain tumor chemotherapy.
Tator CH
Surg Neurol; 1977 Feb; 7(2):73-7. PubMed ID: 835077
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracil.
Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
Cancer Treat Rep; 1978 Oct; 62(10):1603-5. PubMed ID: 361230
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
Williams PD; Kantor P; Murphy GP
Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal cancer. Treatment with fluorouracil-nitrosourea combinations.
Moertel CG
JAMA; 1976 May; 235(19):2135-6. PubMed ID: 946546
[No Abstract] [Full Text] [Related]
11. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Hirst DG; Brown JM; Hazlehurst JL
Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent cytotoxicity of 5-fluorouracil and cyclophosphamide in experimental cancer chemotherapy.
Mulder JH; Smink T; Ossewaarde T; van Putten LM
Eur J Cancer (1965); 1980 May; 16(5):699-705. PubMed ID: 6930341
[No Abstract] [Full Text] [Related]
13. Effect of phospholipids on maintenance of the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in aqueous suspension.
Maker HS; Syed HH; Lehrer GM
J Natl Cancer Inst; 1978 May; 60(5):1055-7. PubMed ID: 642027
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of advanced small-cell anaplastic carcinoma. Superiority of a four-drug combination to a three-drug combination.
Hansen HH; Dombernowsky P; Hansen M; Hirsch F
Ann Intern Med; 1978 Aug; 89(2):177-81. PubMed ID: 209710
[TBL] [Abstract][Full Text] [Related]
15. MItomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma.
Bonomi PD; Chandra G; Rossof AH; Klaassen D
Cancer Chemother Pharmacol; 1980; 5(1):39-42. PubMed ID: 7006846
[TBL] [Abstract][Full Text] [Related]
16. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
[No Abstract] [Full Text] [Related]
17. Adriamycin, CCNU, and 5-fluorouracil in patients with advanced gastrointestinal cancer.
Cedermark BJ; Gunven P; Hammarberg C
J Surg Oncol; 1983 Feb; 22(2):125-8. PubMed ID: 6296546
[TBL] [Abstract][Full Text] [Related]
18. [Comparative assessment of the effectiveness of the preparations CCNU, 5-fluorouracil, ftorafur and their combinations in inoperable stomach cancer].
Voznyĭ EK; Borisov VI; Perevodchikova NI; Babaian LA; Vaarik KhM
Vestn Akad Med Nauk SSSR; 1978; (9):83-7. PubMed ID: 364874
[No Abstract] [Full Text] [Related]
19. 5-Fluorouracil and methotrexate combination chemotherapy: the effect of drug scheduling.
Mulder JH; Smink T; van Putten LM
Eur J Cancer Clin Oncol; 1981 Jul; 17(7):831-7. PubMed ID: 6949765
[No Abstract] [Full Text] [Related]
20. Clinical comparison of the nitrosoureas.
Wasserman TH; Slavik M; Carter SK
Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
